An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab with Standard-of-Care Therapy Against Standard-of-Care Therapy Alone for Advanced HER2-Positive Biliary Tract Cancer BTC

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT06282575

Study #:
STUDY00160707

Start Date:
Oct 25, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06282575

View Complete Trial Details & Eligibility at ClinicalTrials.gov